Skip to content
Homepage
Author:
Step Pharma
Posted Date:
July 1, 2026
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
Step Pharma
July 1, 2026
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
Step Pharma
June 17, 2026
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours
Step Pharma
February 19, 2026
